Tianjin Zhongxin Pharmaceutical Group Corp Ltd - ESG Rating & Company Profile powered by AI
The analysis of Tianjin Zhongxin Pharmaceutical Group Corp Ltd is assembled by All Street Sevva using advanced AI. Other companies in the rating industry group for Tianjin Zhongxin Pharmaceutical Group Corp Ltd are shown. Scroll down to the bottom of the page for potential risks for Tianjin Zhongxin Pharmaceutical Group Corp Ltd based on industry, location and size.
Tianjin Zhongxin Pharmaceutical Group Corp Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Tianjin Zhongxin Pharmaceutical Group Corp Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose current and historical energy intensity?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd report the average age of the workforce?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd reference operational or capital allocation in relation to climate change?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose its ethnicity pay gap?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose cybersecurity risks?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd offer flexible work?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose the number of employees in R&D functions?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd conduct supply chain audits?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd conduct 360 degree staff reviews?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose the individual responsible for D&I?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose current and / or historical scope 2 emissions?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose water use targets?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd have careers partnerships with academic institutions?
Did Tianjin Zhongxin Pharmaceutical Group Corp Ltd have a product recall in the last two years?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose incidents of discrimination?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd allow for Work Councils/Collective Agreements to be formed?
Has Tianjin Zhongxin Pharmaceutical Group Corp Ltd issued a profit warning in the past 24 months?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose parental leave metrics?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose climate scenario or pathway analysis?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose the pay ratio of women to men?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd support suppliers with sustainability related research and development?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Tianjin Zhongxin Pharmaceutical Group Corp Ltd involved in embryonic stem cell research?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose GHG and Air Emissions intensity?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose its waste policy?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd report according to TCFD requirements?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose energy use targets?
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Tianjin Zhongxin Pharmaceutical Group Corp Ltd
These potential risks are based on the size, segment and geographies of the company.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.